성인형스틸씨병에서 TLR4 내인리간드 S1008/A9의 질병활성화 표지자로서 역할 및 임상 양상과의 관련성

Alternative Title
TLR4 endogenous ligand S100A8/A9 levels in adult-onset Still’s disease and their association with disease activity and clinical manifestations
Author(s)
김현아
Advisor
서창희
Department
일반대학원 의학과
Publisher
The Graduate School, Ajou University
Publication Year
2015-08
Language
eng
Keyword
Adult-onset Still’s diseaseS100A8/A9disease activitybiomarkerinterleukin-1β
Alternative Abstract
Objective: S100A8/A9 has been suggested as a biomarker of disease activity in patients with systemic juvenile idiopathic arthritis or adult-onset Still’s disease (AOSD). We investigated the clinical significance and the pathogenic role of this marker in AOSD. Materials and Methods: Serum samples were collected from 36 AOSD patients, 40 rheumatoid arthritis (RA) patients, and 33 healthy controls (HC) for enzyme-linked immunosorbent assay (ELISA) of S100A8/A9, follistatin-like protein 1 and interleukin-18 (IL-18). Of the AOSD patients, follow-up samples were collected from 16 patients after resolution of disease activity. Furthermore, S100A8/A9 expression levels in biopsy specimens obtained from 26 AOSD patients with skin rashes and 8 AOSD with lymphadenopathy were investigated via immunohistochemistry. Peripheral blood mononuclear cells (PBMC) from active AOSD and HC were evaluated for IL-1β release, and in vitro study with PBMC and THP-1 cell line was done for cell signal of S100A8/A9. Results: Serum S100A8/A9 in AOSD patients was higher than those of RA patients and HC. However, follistatin-like protein 1 in AOSD was not different from RA and HC. The IL-18 levels of AOSD were higher than those of RA and HC. Serum S100A8/A9 correlated with leukocyte count, erythrocyte sedimentation rate, C-reactive protein (CRP), ferritin, and systemic score, however the IL-18 correlated only with ferritin and systemic score. In addition, S100A8/A9 was decreased after disease activity was resolved in followed-up AOSD patients. Furthermore, the IL-1β and TNF-α levels of AOSD were higher than those of HC. Serum S100A8/A9 levels correlated with IL-1β, TNF-α, ferritin, and CRP. The grade of inflammatory cells expressing S100A8/A9 ranged from 1 to 3 in skin and lymph node biopsies of active AOSD. The grading of staining of S100A8/A9 was more intense in inflammatory cells of skin lesions with karyrrhexis (p=0.028), mucin deposition (p=0.014), and neutrophil infiltration (p=0.006). Furthermore, the correlation between inflammatory cell grading of CD68 and that of S100A8/A9 was shown (p<0.001) in skin biopsies. S100A9 was a strong inducer of IL-1β expression in peripheral blood mononuclear cells. S100A9 induced signal transduction pathways, including JNK and p38 in PBMC from HC and AOSD patients. Conclusion: The data suggest that serum S100A8/A9 may be a useful biomarker for evaluating disease activity in AOSD patients. Furthermore, S100A8/A9 may contribute to the inflammatory response by induction of inflammatory cytokines, and serve as a clinicopathological marker for assessment of disease activity in AOSD.
URI
https://dspace.ajou.ac.kr/handle/2018.oak/18748
Fulltext

Appears in Collections:
Graduate School of Ajou University > Department of Medicine > 4. Theses(Ph.D)
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse